Tag: neurodegenerative diseases

July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
May 9, 2018

Prothena Reports First Quarter 2018 Financial Results and Provides R&D Update

Prothena (NASDAQ:PRTA), a clinical-stage biotechnology company focused on the discovery and development of novel therapies in the neuroscience and orphan...
April 5, 2018

AC Immune Announces the Selection of Tau Small Molecules for Clinical Development in Alzheimer’s disease

AC Immune (NASDAQ:ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced that...
March 21, 2018

Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene

Prothena Corporation (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in the...
March 20, 2018

AC Immune reports full-year 2017 financial results

AC Immune (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced...
March 19, 2018

Denali Therapeutics Announces Reports Full Year 2017 Financial Results And Business Highlights

Denali Therapeutics (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurodegenerative diseases, today announced that it...
March 14, 2018

Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

Voyager Therapeutics (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today reported its...